ConductScience.org, home

Paper27522158

Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.

Povsic TJ and 15 others. J Allergy Clin Immunol, 2016. Cited by 160 papers, by iCite.

Cite this record

ConductScience Library. Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer. Papers, record 27522158. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27522158

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer.
PubMed
Journal
J Allergy Clin Immunol
PubMed
Year
2016
PubMed
Publication types
Letter, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
160
iCite
Relative citation ratio, by iCite
5.4
iCite
Revised in PubMed
2018-12-02
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Povsic TJThomas J
2Lawrence MGMonica G
3Lincoff AMA Michael
4Mehran RRoxana
5Rusconi CPChristopher P
6Zelenkofske SLSteven L
7Huang ZZhen
8Sailstad JJeffrey
9Armstrong PWPaul W
10Steg PGP Gabriel
11Bode CChristoph
12Becker RCRichard C
13Alexander JHJohn H
14Adkinson NFN Franklin
15Levinson AIArnold I
16REGULATE-PCI InvestigatorsGroup

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntibodiesMajor topic
Aptamers, NucleotideMajor topic
Hypersensitivity, ImmediateMajor topic
Polyethylene GlycolsMajor topic
Clinical Trials, Phase III as Topic
Humans
Multicenter Studies as Topic
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

Cited by96

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.

PMIDTitleJournalYearIn PapersSource
42963446Complement Activation-Related Pseudoallergy (CARPA): An Underrecognized Risk of Drugs, Drug Carriers, and Formulation Vehicles.Clin Rev Allergy Immunol2026https://conductscience.org/library/papers/42963446PubMed
42514893Anti-PEG Immunogenicity of mRNA-LNP Vaccines in Humans: Evidence for Population-Level Changes in the Anti-PEG Antibody Repertoire.Pharmaceutics2026https://conductscience.org/library/papers/42514893PubMed
42149311Protein-protein interaction disruption as a next-generation antithrombotic strategy.J Thromb Thrombolysis2026https://conductscience.org/library/papers/42149311PubMed
42098447Recent advances in the regulation of CD47 by non-coding RNAs and its therapeutic potential in cancer.Clin Transl Oncol2026https://conductscience.org/library/papers/42098447PubMed
41898181From Selection to Use: Aptamers as Targeting Reagents in Hematology.Biomedicines2026https://conductscience.org/library/papers/41898181PubMed
41141388In vivo gene therapy: A strategy for mutations, degenerations, and tumors.Genes Dis2026https://conductscience.org/library/papers/41141388PubMed
41065938Critical appraisal of "Precision nanotherapeutics for kidney disease: targeting inflammation and maladaptive repair".Int Urol Nephrol2026https://conductscience.org/library/papers/41065938PubMed
40871093Anti-PEG Antibodies and Their Biological Impact on PEGylated Drugs: Challenges and Strategies for Optimization.Pharmaceutics2025https://conductscience.org/library/papers/40871093PubMed
40682687Advancements in hydroxypropyl methylcellulose-polyethylene glycol hybrid excipients and their nanoformulations for controlled and ligand-directed biologic delivery.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40682687PubMed
40599554Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair.Cardiol Plus2025https://conductscience.org/library/papers/40599554PubMed
40574110Implications of Anaphylaxis Following mRNA-LNP Vaccines: It Is Urgent to Eliminate PEG and Find Alternatives.Pharmaceutics2025https://conductscience.org/library/papers/40574110PubMed
39978660RNA aptamer-mediated RNA nanotechnology for potential treatment of cardiopulmonary diseases.Pharmacol Res2025https://conductscience.org/library/papers/39978660PubMed
39157078Impact of the Hydrophilicity of Poly(sarcosine) on Poly(ethylene glycol) (PEG) for the Suppression of Anti-PEG Antibody Binding.ACS Omega2024https://conductscience.org/library/papers/39157078PubMed
39119697Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies.ACS Nano2024https://conductscience.org/library/papers/39119697PubMed
38612441Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review.Int J Mol Sci2024https://conductscience.org/library/papers/38612441PubMed
38469811Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in Swine.ACS Nano2024https://conductscience.org/library/papers/38469811PubMed
38400143Right Biceps Pseudo-Tumor from COVID-19 Vaccination.Vaccines (Basel)2024https://conductscience.org/library/papers/38400143PubMed
38394369Antiviral Protein-Protein Interaction Inhibitors.J Med Chem2024https://conductscience.org/library/papers/38394369PubMed
38182056Development of anti-PEG IgG/IgM/IgE ELISA assays for profiling anti-PEG immunoglobulin response in PEG-sensitized individuals and patients with alpha-gal allergy.J Control Release2024https://conductscience.org/library/papers/38182056PubMed
38162136Bivalirudin-hydrogel coatings of polyvinyl chloride on extracorporeal membrane oxygenation for anticoagulation.Front Cardiovasc Med2023https://conductscience.org/library/papers/38162136PubMed

See all 96 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27522158

GET https://conductscience.org/api/papers/v1/27522158/cited_by?page=2